Skip to content
lifestyle.mediatrainingforceos.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lexeo Therapeutics
Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia
June 17, 2026
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia
June 15, 2026
Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 19, 2026
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February
February 11, 2026
←
Previous Page
1
2